Peptide conjugate for magnetic resonance imaging
First Claim
Patent Images
1. Diagnostic agent comprising a compound of formula:
-
(PEPTIDE)n1-(LINKER)n2-(SIGNAL)n3
(I) wherein 1) PEPTIDE is chosen in the group;
a) X1-X2-X3-X4-NHOH
(II), wherein X1 is absent or X1 is a residue of an alpha-amino glycine, X2 is a residue of an amino acid selected from proline, hydroxyproline, thioproline and alanine, X3 is a residue of an amino acid selected from glutamine, glutamic acid, leucine, isoleucine and phenylalanine and X4 is a residue of an alpha-amino acid selected from glycine, alanine, valine, leucine;
and the hydrogen atom of the amino group in said alpha-amino acid X1 may be replaced with a member X0 selected from the group consisting of acetyl, benzoyl (Bz), benzyloxy, t-butyloxycarbonyl, benzyloxycarbonyl (Z), p-aminobenzoyl (ABz), p-amino-benzyl, p-hydroxybenzoyl (HBz), 3-p-hydroxyphenylpropionyl (HPP). b) a peptide functionally equivalent to a peptide of a) c) a peptidic fragment of (II) functionally equivalent to a peptide of a) or b) 2) SIGNAL is a signal entity for medical imaging 3) LINKER eventually absent represents a chemical link between PEPTIDE and SIGNAL;
and the pharmaceutical salts thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to new compounds and compositions for the imaging diagnostic of pathologies, namely for cardiovascular diseases, more precisely atherosclerosis disease. These compounds are contrast agents useful namely in the field of magnetic resonance imaging MRI and nuclear medicine. The compounds comprise a particular peptidic MMP inhibitor coupled with a signal entity.
40 Citations
20 Claims
-
1. Diagnostic agent comprising a compound of formula:
(PEPTIDE)n1-(LINKER)n2-(SIGNAL)n3
(I)wherein 1) PEPTIDE is chosen in the group;
a) X1-X2-X3-X4-NHOH
(II),wherein X1 is absent or X1 is a residue of an alpha-amino glycine, X2 is a residue of an amino acid selected from proline, hydroxyproline, thioproline and alanine, X3 is a residue of an amino acid selected from glutamine, glutamic acid, leucine, isoleucine and phenylalanine and X4 is a residue of an alpha-amino acid selected from glycine, alanine, valine, leucine;
and the hydrogen atom of the amino group in said alpha-amino acid X1 may be replaced with a member X0 selected from the group consisting of acetyl, benzoyl (Bz), benzyloxy, t-butyloxycarbonyl, benzyloxycarbonyl (Z), p-aminobenzoyl (ABz), p-amino-benzyl, p-hydroxybenzoyl (HBz), 3-p-hydroxyphenylpropionyl (HPP). b) a peptide functionally equivalent to a peptide of a) c) a peptidic fragment of (II) functionally equivalent to a peptide of a) or b) 2) SIGNAL is a signal entity for medical imaging 3) LINKER eventually absent represents a chemical link between PEPTIDE and SIGNAL;
and the pharmaceutical salts thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
10. (canceled)
-
11. (canceled)
Specification